Wallace advises the shareholders of Regulis Consulting on its merger with the PharmaLex Group
Wallace advises the shareholders of Regulis Consulting on its merger with the PharmaLex Group
The Wallace team recently advised the founders of Regulis, Kim and Gill Wharton, on the recent merger with PharmaLex.
Regulis was founded in 2001 and has grown to be a leading consultancy specialising in regulatory affairs, pharmacovigilance and quality assurance.
PharmaLex is a leading provider of specialised services for the pharma, biotech and medical device industries worldwide.
Corporate partner John Woodhouse led the Wallace team, assisted by senior associate Laura Gillard and corporate associate Sabrina Mitchell. Head of Employment, Daniel Isaac advised the founders on new employment arrangements.
John Woodhouse commented:
“We were delighted to assist Kim and Gill Wharton on the successful integration of the Regulis business into the PharmaLex Group. Over the last decade we have developed a specialism of advising consulting businesses on realising value for shareholders and the Regulis deal represents the latest in a long list of successful transactions.”
“John Woodhouse and his team provided excellent and unstinting support and were a real pleasure to work with.”